Literature DB >> 22454951

The effects of salbutamol and terbutaline on physiological tremor, bronchial tone and heart rate.

J M Watson1, A Richens.   

Abstract

1 The effects of oral doses of the bronchodilator drugs, salbutamol (4 and 8 mg) and terbutaline (5 and 10 mg), on physiological tremor, bronchial tone, heart rate and blood pressure were studied in six normal subjects. 2 Both drugs produced a significant increase in physiological tremor, compared with placebo. Terbutaline, but not salbutamol, produced a dose related response. No significant differences were observed between drugs. 3 Terbutaline (5 and 10 mg) and salbutamol (8 mg) produced a significant bronchodilatation compared with placebo. Dose related responses were obtained with both drugs, although this reached significance only with terbutaline. 4 Both doses of each drug produced a tachycardia, although this was only statistically significant with the high doses. 5 No significant change in blood pressure was observed with either drug. 6 Peak effects of salbutamol occurred between 1 and 3 h and terbutaline between 1 and 4 hours. Both drugs were still active at 6 hours.

Entities:  

Year:  1974        PMID: 22454951      PMCID: PMC1402544          DOI: 10.1111/j.1365-2125.1974.tb00240.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  19 in total

1.  The effects of adrenaline, noradrenaline and isoprenaline on skeletal muscle contractions in the cat.

Authors:  W C BOWMAN; E ZAIMIS
Journal:  J Physiol       Date:  1958-11-10       Impact factor: 5.182

2.  Spasticity alleviation by drugs acting directly on skeletal muscle.

Authors:  E Zaimis
Journal:  Lancet       Date:  1973-02-24       Impact factor: 79.321

3.  The metabolism of terbutaline in man.

Authors:  H T Nilsson; K Persson; K Tegnér
Journal:  Xenobiotica       Date:  1972-07       Impact factor: 1.908

4.  A new bronchodilator: terbutaline.

Authors:  P Dinda; A Bernstein; S S Chatterjee
Journal:  Br J Clin Pract       Date:  1971-07

5.  Metabolic studies of Salbutanol-3H: a new bronchodilator, in rat, rabbit, dog and man.

Authors:  L E Martin; J C Hobson; J A Page; C Harrison
Journal:  Eur J Pharmacol       Date:  1971-04       Impact factor: 4.432

6.  Clinical comparison of inhaled terbutaline and orciprenaline in asthmatic patients.

Authors:  H Formgren
Journal:  Scand J Respir Dis       Date:  1970

7.  Practical experience with salbutamol by mouth.

Authors:  F J Prime
Journal:  Postgrad Med J       Date:  1971-03       Impact factor: 2.401

8.  Initial studies on the human pharmacology of salbutamol.

Authors:  W T Simpson
Journal:  Postgrad Med J       Date:  1971-03       Impact factor: 2.401

9.  Evaluation of a new B 2 adrenergic receptor stimulant, terbutaline, in bronchial asthma. II. Oral comparison with ephedrine.

Authors:  M J Dulfano; P Glass
Journal:  Curr Ther Res Clin Exp       Date:  1973-04

10.  Actions of the sympathomimetic bronchodilator, rimiterol (R798), on the cardiovascular, respiratory and skeletal muscle systems of the anaesthetized cat.

Authors:  W C Bowman; I W Rodger
Journal:  Br J Pharmacol       Date:  1972-08       Impact factor: 8.739

View more
  4 in total

1.  Comparison of the efficacy and systemic effects of 4 mg and 8 mg formulations of salbutamol controlled release in patients with asthma.

Authors:  B J Lipworth; R A Clark; D P Dhillon; J B Palmer; D G McDevitt
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

2.  Effects of acute hypoxia on postural and kinetic tremor.

Authors:  A Legros; H R Marshall; A Beuter; J Gow; B Cheung; A W Thomas; F S Prato; R Z Stodilka
Journal:  Eur J Appl Physiol       Date:  2010-04-23       Impact factor: 3.078

3.  Salmefamol orally in asthmatics - two doses compared.

Authors:  R W Sillett; C H Dash; M W McNicol
Journal:  Eur J Clin Pharmacol       Date:  1976-02-06       Impact factor: 2.953

4.  Single dose and steady-state pharmacokinetics of 4 mg and 8 mg oral salbutamol controlled-release in patients with bronchial asthma.

Authors:  B J Lipworth; R A Clark; D P Dhillon; M K Charter; J B Palmer; D G McDevitt
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.